e-Therapeutics (LSE:ETX) Selling and Marketing Expense : £0.00 Mil (TTM As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is e-Therapeutics Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. e-Therapeutics's Selling and Marketing Expense for the six months ended in Jul. 2023 was £0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jul. 2023 was £0.00 Mil.

e-Therapeutics Selling and Marketing Expense Historical Data

The historical data trend for e-Therapeutics's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

e-Therapeutics Selling and Marketing Expense Chart

e-Therapeutics Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Selling and Marketing Expense

Get a 7-Day Free Trial

e-Therapeutics Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
Selling and Marketing Expense	Get a 7-Day Free Trial															-	-	-	-	-

e-Therapeutics Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jul. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

e-Therapeutics Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of e-Therapeutics's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

e-Therapeutics (LSE:ETX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » e-Therapeutics PLC (LSE:ETX) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

ETXPF:USA

Address

4 Kingdom Street, Paddington, London, GBR, W2 6BD

Website

https://www.etherapeutics.co.uk

e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.

e-Therapeutics (LSE:ETX) Headlines

From GuruFocus

Eaton Vance Municipal Income 2028 Term Trust Announces Telephonic Annual Meeting Of Shareholders On November 12, 2021

By PRNewswire PRNewswire • 11-02-2021